Veselovská Lucia, Pohl Radek, Tloušt Ová Eva, Gurská Soňa, Džubák Petr, Hajdúch Marián, Hocek Michal
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Hnìvotínská 5, CZ-77515 Olomouc, Czech Republic.
ACS Omega. 2020 Oct 2;5(40):26278-26286. doi: 10.1021/acsomega.0c04302. eCollection 2020 Oct 13.
Two isomeric sets of 4-substituted pyridopyrrolopyrimidine nucleobases were prepared through nucleophilic substitutions or cross-coupling reactions of 4-chloropyridopyrrolopyrimidines. The corresponding 4-amino-pyridopyrrolopyrimidines were glycosylated with 5--tritylribose using the modified Mitsunobu protocol. Several examples of the title heterocycles showed blue or green fluorescence. Testing of the pyridopyrrolopyrimidine nucleobases for the cytotoxic effect revealed micromolar activity of 4-benzofuryl derivatives in both series, preferentially in multidrug-resistant cancers.
通过4-氯代吡啶并吡咯并嘧啶的亲核取代或交叉偶联反应制备了两组4-取代吡啶并吡咯并嘧啶核碱基的异构体。使用改良的 Mitsunobu 方法,相应的4-氨基吡啶并吡咯并嘧啶与5-O-三苯甲基核糖进行糖基化反应。几个标题杂环化合物的例子显示出蓝色或绿色荧光。对吡啶并吡咯并嘧啶核碱基的细胞毒性作用测试表明,两个系列中的4-苯并呋喃基衍生物均具有微摩尔活性,在多药耐药性癌症中活性更高。